URGENT.LY INC (ULY)

US9169311084 - Common Stock

0.5358  +0.09 (+20.4%)

After market: 0.515 -0.02 (-3.88%)

Fundamental Rating

2

Taking everything into account, ULY scores 2 out of 10 in our fundamental rating. ULY was compared to 279 industry peers in the Software industry. ULY has a bad profitability rating. Also its financial health evaluation is rather negative. ULY has a correct valuation and a medium growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year ULY was profitable.
ULY had a negative operating cash flow in the past year.
ULY had negative earnings in 4 of the past 5 years.
In the past 5 years ULY always reported negative operating cash flow.

1.2 Ratios

ULY has a Return On Assets of 104.76%. This is amongst the best in the industry. ULY outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 104.76%
ROE N/A
ROIC N/A
ROA(3y)-12.82%
ROA(5y)-37.69%
ROE(3y)222.47%
ROE(5y)92.81%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ULY has a better Profit Margin (44.78%) than 97.85% of its industry peers.
With a Gross Margin value of 21.75%, ULY is not doing good in the industry: 84.23% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ULY has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 44.78%
GM 21.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.07%
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

ULY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ULY has more shares outstanding
The debt/assets ratio for ULY is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -3.76, we must say that ULY is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -3.76, ULY is not doing good in the industry: 84.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.76
ROIC/WACCN/A
WACC21.74%

2.3 Liquidity

ULY has a Current Ratio of 0.69. This is a bad value and indicates that ULY is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.69, ULY is doing worse than 87.46% of the companies in the same industry.
ULY has a Quick Ratio of 0.69. This is a bad value and indicates that ULY is not financially healthy enough and could expect problems in meeting its short term obligations.
ULY has a Quick ratio of 0.69. This is amonst the worse of the industry: ULY underperforms 87.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.69

5

3. Growth

3.1 Past

ULY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 182.43%, which is quite impressive.
The Revenue for ULY has decreased by -16.15% in the past year. This is quite bad
Measured over the past years, ULY shows a very strong growth in Revenue. The Revenue has been growing by 679.41% on average per year.
EPS 1Y (TTM)182.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.17%
Revenue 1Y (TTM)-16.15%
Revenue growth 3Y679.41%
Revenue growth 5YN/A
Sales Q2Q%-21.47%

3.2 Future

The Earnings Per Share is expected to grow by 26.08% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.81% on average over the next years.
EPS Next Y38.25%
EPS Next 2Y35.72%
EPS Next 3Y26.08%
EPS Next 5YN/A
Revenue Next Year-18.29%
Revenue Next 2Y-0.82%
Revenue Next 3Y5.81%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.10, which indicates a rather cheap valuation of ULY.
100.00% of the companies in the same industry are more expensive than ULY, based on the Price/Earnings ratio.
ULY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.20.
ULY is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 0.1
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ULY's earnings are expected to grow with 26.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y35.72%
EPS Next 3Y26.08%

0

5. Dividend

5.1 Amount

ULY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

URGENT.LY INC

NASDAQ:ULY (11/22/2024, 8:10:32 PM)

After market: 0.515 -0.02 (-3.88%)

0.5358

+0.09 (+20.4%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.23M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 0.1
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 104.76%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 44.78%
GM 21.75%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)182.43%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y38.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-16.15%
Revenue growth 3Y679.41%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y